These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 2196238

  • 1. Immunoglobulin G, complement factor C3 and lymphocytes in proliferative intraocular disorders.
    Weller M, Clausen R, Bresgen M, Heimann K, Wiedemann P.
    Int Ophthalmol; 1990 Jul; 14(4):277-83. PubMed ID: 2196238
    [Abstract] [Full Text] [Related]

  • 2. The significance of complement in proliferative vitreoretinopathy.
    Grisanti S, Wiedemann P, Weller M, Heimann K, Zilles K.
    Invest Ophthalmol Vis Sci; 1991 Sep; 32(10):2711-7. PubMed ID: 1894471
    [Abstract] [Full Text] [Related]

  • 3. [Proliferative vitreoretinopathy. Activation of the complement system].
    Grisanti S, Esser P, Weller M, Wiedemann P, Heimann K.
    Ophthalmologe; 1992 Feb; 89(1):50-4. PubMed ID: 1533804
    [Abstract] [Full Text] [Related]

  • 4. Cytokines in vitreous humor: interleukin-6 is elevated in proliferative vitreoretinopathy.
    Kauffmann DJ, van Meurs JC, Mertens DA, Peperkamp E, Master C, Gerritsen ME.
    Invest Ophthalmol Vis Sci; 1994 Mar; 35(3):900-6. PubMed ID: 8125753
    [Abstract] [Full Text] [Related]

  • 5. Iron-binding proteins in the human vitreous: lactoferrin and transferrin in health and in proliferative intraocular disorders.
    Weller M, Clausen R, Heimann K, Wiedemann P.
    Ophthalmic Res; 1990 Mar; 22(3):194-200. PubMed ID: 2385435
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Vitronectin and proliferative intraocular disorders. I. A colocalisation study of the serum spreading factor, vitronectin, and fibronectin in traction membranes from patients with proliferative vitreoretinopathy.
    Weller M, Wiedemann P, Bresgen M, Heimann K.
    Int Ophthalmol; 1991 Mar; 15(2):93-101. PubMed ID: 1708748
    [Abstract] [Full Text] [Related]

  • 10. Vitreous vascular endothelial growth factor concentrations in proliferative diabetic retinopathy versus proliferative vitreoretinopathy.
    Citirik M, Kabatas EU, Batman C, Akin KO, Kabatas N.
    Ophthalmic Res; 2012 Mar; 47(1):7-12. PubMed ID: 21691136
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Intercellular adhesion molecule-1 levels in plasma and vitreous from patients with vitreoretinal disorders.
    Esser P, Bresgen M, Fischbach R, Heimann K, Wiedemann P.
    Ger J Ophthalmol; 1995 Sep; 4(5):269-74. PubMed ID: 7496336
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Immunolocalization of integrins in proliferative retinal membranes.
    Robbins SG, Brem RB, Wilson DJ, O'Rourke LM, Robertson JE, Westra I, Planck SR, Rosenbaum JT.
    Invest Ophthalmol Vis Sci; 1994 Aug; 35(9):3475-85. PubMed ID: 8056523
    [Abstract] [Full Text] [Related]

  • 20. Expression of HLA-DR antigen in epiretinal and vitreous membranes.
    Tang SB, Scheiffarth OF.
    Yan Ke Xue Bao; 1989 Jun; 5(1-2):28-31, 59. PubMed ID: 2485739
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.